Zhongshan Hospital (Xiamen), Fudan University

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Chidamide Monotherapy for Intermediate-to-High-Risk Myelodysplastic Syndromes	Hemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder, myelodysplastic syndrome	Not yet recruiting	Phase 2	2026-06-01		NCT07616336

Clinical trials